Moreover, after cell cycle synchronization using thymidine and release at the G1/S phase, CDK1 kinase activity in NQO1-deficient cancer cells was concurrently increased, as it was in NQO1-expressing cancer cells, but the decrease was delayed (Figure 2E,F). This evidence concerns the gene NQO1 and cancer.